Recent Updates
Recently added Catalysts
APYX Positive Sentiment

APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON MAY 9, 2024

Key Takeaway: Apyx Medical Corporation will announce its financial results for Q1 of fiscal year 2024 on May 9, 2024. A conference call is scheduled for the same day at 8:00 a.m. ET, allowing investors to discuss the results and ask questions. The company specializes in advanced energy technology, particularly in cosmetic and surgical markets.
Price reaction · baseline $1.5 (2024-04-24 close) · hit after-hours · clean, no other APYX news in the window
day 0 close
-1.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Apyx Medical Corporation is set to release its financial results, indicating transparency.
  • The company is hosting a conference call to discuss results, promoting investor engagement.
  • Renuvion and J-Plasma technologies are well-supported by clinical documentation.

Full Press Release Details

CLEARWATER, FL — April 25, 2024 – Apyx ® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that financial results for the first quarter of fiscal year 2024 will be released before the market opens on Thursday, May 9th.
Management will host a conference call at 8:00 a.m. Eastern Time on May 9th to discuss the results of the quarter, and to host a question and answer session. To listen to the call by phone, interested parties may dial 888-645-4404 (or 862-298-0702 for international callers) and provide access code 13745889. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Company’s website and via the following link: Apyx Medical Earnings Webcast
A telephonic replay will be available approximately three hours after the call ends through the following two weeks. The replay can be accessed by dialing 877-660-6853 for U.S. callers or 201-612-7415 for international callers and using the replay access code: 13745889. The webcast will be archived on the Investor Relations section of the Company’s website.
Investor Relations Contact : ICR Westwicke on behalf of Apyx Medical Corporation Mike Piccinino, CFA investor.relations@apyxmedical.com
About Apyx Medical Corporation : Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma ® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com .

Frequently Asked Questions

When will Apyx Medical release its financial results?

Apyx Medical will release its financial results on May 9, 2024.

What time is the Apyx Medical conference call?

The conference call is scheduled for 8:00 a.m. Eastern Time on May 9, 2024.

How can I access the Apyx Medical conference call?

You can dial 888-645-4404 or listen via the webcast on their website.

What technologies does Apyx Medical offer?

Apyx Medical offers Renuvion and J-Plasma technologies for cosmetic and surgical markets.

Last updated: Apr 25, 2024